
Sign up to save your podcasts
Or
Full article: https://www.ajronline.org/doi/10.2214/AJR.22.28385
Locoregional therapies for hepatocellular carcinoma perform differently when compared by rates of complete pathologic necrosis of lesions. Juliet Alla, MD discusses a new AJR study that demonstrates improved rates of complete pathologic necrosis for patients with HCC who underwent thermal ablation and TARE therapies, when compared to those who received TACE. Special guest Dr. Zachary Berman, an interventional radiologist who specializes in locoregional therapies for hepatocellular carcinoma, joins to discuss the implications for clinical practice.
4.5
4343 ratings
Full article: https://www.ajronline.org/doi/10.2214/AJR.22.28385
Locoregional therapies for hepatocellular carcinoma perform differently when compared by rates of complete pathologic necrosis of lesions. Juliet Alla, MD discusses a new AJR study that demonstrates improved rates of complete pathologic necrosis for patients with HCC who underwent thermal ablation and TARE therapies, when compared to those who received TACE. Special guest Dr. Zachary Berman, an interventional radiologist who specializes in locoregional therapies for hepatocellular carcinoma, joins to discuss the implications for clinical practice.
16,500 Listeners
85 Listeners
27 Listeners
317 Listeners
26,408 Listeners
74 Listeners
27 Listeners
7,769 Listeners
6,633 Listeners
5,085 Listeners
200 Listeners
5,348 Listeners
15,325 Listeners
39 Listeners
420 Listeners